These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 25963018)

  • 21. Methodology of clinical trials for rare diseases.
    Tudur Smith C; Williamson PR; Beresford MW
    Best Pract Res Clin Rheumatol; 2014 Apr; 28(2):247-62. PubMed ID: 24974061
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare Gynecologic Tumors: Coming of Age.
    Gershenson DM; Okamoto A; Ray-Coquard I
    Gynecol Oncol; 2020 Apr; 157(1):1-2. PubMed ID: 32241340
    [No Abstract]   [Full Text] [Related]  

  • 23. Research methods to change clinical practice for patients with rare cancers.
    Billingham L; Malottki K; Steven N
    Lancet Oncol; 2016 Feb; 17(2):e70-e80. PubMed ID: 26868356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A quarter of patients with rarer cancers see GPs several times before referral.
    Mayor S
    BMJ; 2016 Feb; 352():i1198. PubMed ID: 26929277
    [No Abstract]   [Full Text] [Related]  

  • 25. [Centralized treatment of rare types of cancer].
    Schem BC
    Tidsskr Nor Laegeforen; 2002 Sep; 122(21):2088. PubMed ID: 12555641
    [No Abstract]   [Full Text] [Related]  

  • 26. Randomised controlled trials: understanding effect sizes.
    Sedgwick P
    BMJ; 2015 Mar; 350():h1690. PubMed ID: 25820302
    [No Abstract]   [Full Text] [Related]  

  • 27. Rare cancers: A network for better care.
    Sandrucci S; Gatta G
    Eur J Surg Oncol; 2019 Jan; 45(1):1-2. PubMed ID: 30041942
    [No Abstract]   [Full Text] [Related]  

  • 28. Rare cancers: the greatest inequality in cancer research and oncology treatment.
    Alvi MA; Wilson RH; Salto-Tellez M
    Br J Cancer; 2017 Oct; 117(9):1255-1257. PubMed ID: 28934760
    [No Abstract]   [Full Text] [Related]  

  • 29. Can external and subjective information ever be used to reduce the size of randomised controlled trials?
    Tan SB; Wee J; Wong HB; Machin D
    Contemp Clin Trials; 2008 Mar; 29(2):211-9. PubMed ID: 17720629
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The founding of the European Cooperative Study Group on Pediatric Rare Tumors--EXPeRT.
    Ferrari A; Schneider DT; Bisogno G;
    Expert Rev Anticancer Ther; 2013 Jan; 13(1):1-3. PubMed ID: 23259419
    [No Abstract]   [Full Text] [Related]  

  • 31. Editorial: Special issue on rare cancers.
    Sandler A; Reilly K; Widemann B
    Curr Probl Cancer; 2021 Aug; 45(4):100774. PubMed ID: 34304884
    [No Abstract]   [Full Text] [Related]  

  • 32. [Orphan diseases: evaluations of new treatments].
    Bergmann JF; Delcey V; Champion K
    Rev Med Interne; 2007 Oct; 28 Suppl 2():S202-5. PubMed ID: 18228689
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A structured approach to uncommon cancers: what should a clinician do?
    Raghavan D
    Ann Oncol; 2013 Dec; 24(12):2932-4. PubMed ID: 24192449
    [No Abstract]   [Full Text] [Related]  

  • 34. Networking in rare cancers: What was done, what's next.
    Frezza AM; Trama A; Blay JY; Casali PG
    Eur J Surg Oncol; 2019 Jan; 45(1):16-18. PubMed ID: 29685758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Challenges for clinical research on rare tumors in Europe].
    Blay JY
    Bull Acad Natl Med; 2013 Jan; 197(1):103-21; discussion 121-2. PubMed ID: 24672983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Testing the wrong hypothesis in phase II oncology trials: there is a better alternative.
    Ratain MJ; Karrison TG
    Clin Cancer Res; 2007 Feb; 13(3):781-2. PubMed ID: 17289865
    [No Abstract]   [Full Text] [Related]  

  • 37. A unifying strategy for clinical trials in rare urological malignancy.
    Nicholson S
    Nat Clin Pract Urol; 2008 Dec; 5(12):652-3. PubMed ID: 19015645
    [No Abstract]   [Full Text] [Related]  

  • 38. [The method of conducting randomized trials in cancerology must be changed].
    Hill C
    Bull Cancer; 2002 Sep; 89(9):823-5. PubMed ID: 12368134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Need for expertise based randomised controlled trials: expertise based design has shortfalls.
    Lim E
    BMJ; 2005 Apr; 330(7494):791-2. PubMed ID: 15802732
    [No Abstract]   [Full Text] [Related]  

  • 40. Providing guidance in the dark: rare renal diseases and the challenge to improve the quality of evidence.
    Bolignano D; Nagler EV; Van Biesen W; Zoccali C
    Nephrol Dial Transplant; 2014 Sep; 29(9):1628-32. PubMed ID: 24026240
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.